{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:14:06Z","timestamp":1788502446873,"version":"build-2803163510"},"reference-count":125,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Cardiac amyloidosis (CA) represents a growing etiology of heart failure (HF) and arrhythmogenesis, driven by the intramyocardial deposition of aberrantly folded proteins, notably immunoglobulin light chains (AL) and transthyretin (ATTR). This infiltrative process compromises myocardial compliance and disrupts the cardiac conduction system, leading to a diverse spectrum of dysrhythmias. The escalating prevalence of CA, particularly within geriatric demographics and individuals with plasma cell dyscrasias, underscores the imperative for refined diagnostic and therapeutic paradigms. The considerable arrhythmic burden in CA significantly contributes to patient morbidity, thromboembolic events, and sudden cardiac death, thus providing the impetus for this comprehensive review. Despite advancements in cardiac imaging and biomarker analysis, detailed electrophysiological characterization and arrhythmia-specific management strategies in CA remain incompletely elucidated. This review aims to provide a comprehensive overview of current evidence related to the arrhythmic features of CA. In addition, it characterizes the electrophysiological consequences of amyloid infiltration, distinguishes arrhythmic profiles between AL and ATTR subtypes, and evaluates diagnostic methods and treatment options to optimize clinical management decision-making. Atrial fibrillation is a prevalent arrhythmia, particularly in wild-type ATTR amyloidosis. In contrast, AL amyloidosis, characterized by direct myocyte cytotoxicity and accelerated disease progression, frequently manifests with ventricular arrhythmias and conduction disturbances. Ultimately, arrhythmias in CA are multifactorial, necessitating a subtype-specific approach to diagnosis and treatment. Risk stratification, integrating electrocardiographic, imaging, biomarker, and genetic data, is crucial for guiding patient management. Future directions involve personalized treatment frameworks leveraging multiomics integration, remote rhythm monitoring, and artificial intelligence-driven predictive modeling to advance precision electrophysiology in systemic amyloidosis.<\/jats:p>","DOI":"10.4103\/heartviews.heartviews_167_25","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:00:12Z","timestamp":1788501612000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Arrhythmic Burden of Cardiac Amyloidosis: A Comprehensive Review"],"prefix":"10.4103","volume":"27","author":[{"given":"Adel Khalifa Sultan","family":"Hamad","sequence":"first","affiliation":[{"name":"Department of Electrophysiology, Mohammed bin Khalifa bin Salman Al Khalifa Cardiac Centre, Awali, Kingdom of Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1]]},"reference":[{"key":"R2-20260904","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000506696","article-title":"The pathology of amyloidosis in classification: A review","volume":"143","author":"Picken","year":"2020","journal-title":"Acta Haematol"},{"key":"R4-20260904","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.19102\/icrm.2018.090301","article-title":"Arrhythmias in cardiac amyloidosis","volume":"9","author":"John","year":"2018","journal-title":"J Innov Card Rhythm Manag"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s10741-021-10162-1","article-title":"Epidemiology and clinical manifestations of cardiac amyloidosis","volume":"27","author":"Bajwa","year":"2022","journal-title":"Heart Fail Rev"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of arrhythmias in cardiac amyloidosis","volume":"6","author":"Giancaterino","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"R7-20260904","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3390\/jcm12072581","article-title":"Arrhythmic manifestations of cardiac amyloidosis: Challenges in risk stratification and clinical management","volume":"12","author":"Laptseva","year":"2023","journal-title":"J Clin Med"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"R9-20260904","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcmg.2022.12.015","article-title":"Myocardial perfusion PET for the detection and reporting of coronary microvascular dysfunction: A JACC: Cardiovascular imaging expert panel statement","volume":"16","author":"Schindler","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"R10-20260904","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"78","author":"Del Buono","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R11-20260904","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1161\/CIRCRESAHA.121.318187","article-title":"Pathophysiology and therapeutic approaches to cardiac amyloidosis","volume":"128","author":"Griffin","year":"2021","journal-title":"Circ Res"},{"key":"R12-20260904","first-page":"104888","article-title":"Sustained ventricular arrhythmia and sinus node dysfunction revealing a cardiac amyloidosis: A case report","volume":"84","author":"Machraa","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.hrthm.2023.01.004","article-title":"New insights into atrioventricular nodal anatomy, physiology, and immunochemistry: A comprehensive review and a proposed model of the slow-fast atrioventricular nodal reentrant tachycardia circuit in agreement with direct potential recordings in the Koch\u2019s triangle area","volume":"20","author":"Pandozi","year":"2023","journal-title":"Heart Rhythm"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"e020358","DOI":"10.1161\/JAHA.120.020358","article-title":"Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis","volume":"10","author":"Pucci","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ncn3.12601","article-title":"Amyloid neuropathy and autonomic dysfunction","volume":"10","author":"Ikeda","year":"2022","journal-title":"Neurol Clin Neurosci"},{"key":"R16-20260904","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41569-022-00818-2","article-title":"The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis","volume":"20","author":"Sud","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"R17-20260904","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaccao.2021.07.010","article-title":"Electrophysiological manifestations of cardiac amyloidosis: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Hartnett","year":"2021","journal-title":"JACC CardioOncol"},{"key":"R18-20260904","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.3390\/jcm13113088","article-title":"Management of arrhythmias and conduction disorders in amyloid cardiomyopathy","volume":"13","author":"Holcman","year":"2024","journal-title":"J Clin Med"},{"key":"R19-20260904","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tcm.2023.02.004","article-title":"Conduction system disease in cardiac amyloidosis","volume":"34","author":"Assaf","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"R20-20260904","first-page":"2199","article-title":"Structural cardiac remodeling in atrial fibrillation","volume":"14","author":"Beyer","year":"2021","journal-title":"Cardiovasc Imaging"},{"key":"R21-20260904","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jjcc.2024.05.007","article-title":"Atrial structural remodeling and atrial fibrillation substrate: A histopathological perspective","volume":"85","author":"Yamaguchi","year":"2025","journal-title":"J Cardiol"},{"key":"R22-20260904","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.jacc.2021.04.012","article-title":"Prevention of pathological atrial remodeling and atrial fibrillation: JACC state-of-the-art review","volume":"77","author":"Chen","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/ijms23010006","article-title":"Atrial fibrillation: Pathogenesis, predisposing factors, and genetics","volume":"23","author":"Sagris","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R24-20260904","first-page":"1111","article-title":"Left ventricular remodeling after myocardial infarction: From physiopathology to treatment","volume":"12","author":"Leanc\u0103","year":"2022","journal-title":"Life (Basel)"},{"key":"R25-20260904","first-page":"369","article-title":"A comprehensive review of cardiac amyloidosis: Advances in diagnosis, clinical manifestations and therapeutic strategies","volume":"15","author":"Agayeva","year":"2024","journal-title":"Syst Rev Pharm"},{"key":"R26-20260904","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: Epidemiology, pathophysiology, and clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res"},{"key":"R27-20260904","first-page":"179","article-title":"Sinus node dysfunction","volume":"104","author":"Hawks","year":"2021","journal-title":"Am Fam Physician"},{"key":"R28-20260904","doi-asserted-by":"crossref","first-page":"e017692","DOI":"10.1161\/JAHA.120.017692","article-title":"Heart failure, atrioventricular block, and ventricular tachycardia in sarcoidosis","volume":"10","author":"Rosenthal","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"R29-20260904","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1038\/s41467-023-40196-y","article-title":"Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value","volume":"14","author":"Enr\u00edquez-V\u00e1zquez","year":"2023","journal-title":"Nat Commun"},{"key":"R30-20260904","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.hrthm.2024.01.056","article-title":"Atrial electrofunctional predictors of incident atrial fibrillation in cardiac amyloidosis","volume":"21","author":"Sinigiani","year":"2024","journal-title":"Heart Rhythm"},{"key":"R31-20260904","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/jcdd10080337","article-title":"Arrhythmias in patients with cardiac amyloidosis: A comprehensive review on clinical management and devices","volume":"10","author":"Briasoulis","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"R32-20260904","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s44325-025-00043-z","article-title":"Atrial cardiomyopathy in cardiac amyloidosis: Clinical imaging and manifestations","volume":"2","author":"Gorrie","year":"2025","journal-title":"NPJ Cardiovasc Health"},{"key":"R33-20260904","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1002\/ehf2.13526","article-title":"Heart failure and atrial flutter: A systematic review of current knowledge and practices","volume":"8","author":"Diamant","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R34-20260904","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15420\/aer.2019.17.2","article-title":"Atrial tachycardias and atypical atrial flutters: Mechanisms and approaches to ablation","volume":"8","author":"Markowitz","year":"2019","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"R35-20260904","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacep.2022.08.022","article-title":"Atrial standstill in the pediatric population: A multi-institution collaboration","volume":"9","author":"Howard","year":"2023","journal-title":"Clin Electrophysiol"},{"key":"R36-20260904","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.3390\/jcm13133921","article-title":"Atrial fibrillation, atrial myopathy, and thromboembolism: The additive value of echocardiography and possible new horizons for risk stratification","volume":"13","author":"Campora","year":"2024","journal-title":"J Clin Med"},{"key":"R37-20260904","first-page":"e9842","article-title":"Association of arrhythmias in cardiac amyloidosis and cardiac sarcoidosis","volume":"12","author":"Ashraf","year":"2020","journal-title":"Cureus"},{"key":"R38-20260904","doi-asserted-by":"crossref","first-page":"1179546820963055","DOI":"10.1177\/1179546820963055","article-title":"Ventricular arrhythmias in cardiac amyloidosis: A review of current literature","volume":"14","author":"Khanna","year":"2020","journal-title":"Clin Med Insights Cardiol"},{"key":"R39-20260904","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.3390\/jcm13185588","article-title":"Electrocardiographic patterns and arrhythmias in cardiac amyloidosis: From diagnosis to therapeutic management-a narrative review","volume":"13","author":"Teresi","year":"2024","journal-title":"J Clin Med"},{"key":"R40-20260904","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ejhf.2769","article-title":"N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis","volume":"25","author":"Vergaro","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"R41-20260904","doi-asserted-by":"crossref","first-page":"euae063","DOI":"10.1093\/europace\/euae063","article-title":"Prognostic implications of premature ventricular contractions and non-sustained ventricular tachycardia in light-chain cardiac amyloidosis","volume":"26","author":"Chen","year":"2024","journal-title":"Europace"},{"key":"R42-20260904","first-page":"416","article-title":"Arrhythmias in cardiac amyloidosis: Challenges in risk stratification and treatment","volume":"36","author":"Cheung","year":"2020","journal-title":"Can J Cardiol"},{"key":"R43-20260904","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/pace.14107","article-title":"Anatomy of the cardiac conduction system","volume":"44","author":"Padala","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"key":"R44-20260904","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/1573403X16666200511090151","article-title":"Conduction disorders: The value of surface ECG","volume":"17","author":"da Silva","year":"2021","journal-title":"Curr Cardiol Rev"},{"key":"R45-20260904","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1111\/pace.14375","article-title":"Conduction abnormalities and role of cardiac pacing in cardiac amyloidosis: A systematic review","volume":"44","author":"Alreshq","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"key":"R46-20260904","doi-asserted-by":"crossref","first-page":"H259","DOI":"10.1152\/ajpheart.00618.2022","article-title":"Sinus node dysfunction: Current understanding and future directions","volume":"324","author":"Manoj","year":"2023","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R47-20260904","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jacc.2018.10.043","article-title":"2018 ACC\/AHA\/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: Executive summary: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines, and the heart rhythm society","volume":"74","author":"Kusumoto","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R48-20260904","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.118.038648","article-title":"Intracardiac delineation of septal conduction in left bundle-branch block patterns: Mechanistic evidence of left intrahisian block circumvented by his bundle pacing","volume":"139","author":"Upadhyay","year":"2019","journal-title":"Circulation"},{"key":"R49-20260904","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/jcdd13010044","article-title":"Novel cut-off values of precordial voltage indexes for light chain amyloidosis cardiomyopathy in a Chinese population","volume":"13","author":"Pan","year":"2026","journal-title":"J Cardiovasc Dev Dis"},{"key":"R50-20260904","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/13506129.2019.1625322","article-title":"Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders","volume":"26","author":"L\u00f3pez-Sainz","year":"2019","journal-title":"Amyloid"},{"key":"R51-20260904","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3390\/jcm13051300","article-title":"Arrhythmias and device therapies in cardiac amyloidosis","volume":"13","author":"Bukhari","year":"2024","journal-title":"J Clin Med"},{"key":"R52-20260904","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tcm.2023.02.006","article-title":"Electrocardiographic features and rhythm disorders in cardiac amyloidosis","volume":"34","author":"Martini","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"R53-20260904","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40271-017-0273-5","article-title":"Light chain (AL) amyloidosis: The journey to diagnosis","volume":"11","author":"McCausland","year":"2018","journal-title":"Patient Patient Cent Outcomes Res"},{"key":"R54-20260904","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/heartjnl-2016-310704","article-title":"Light-chain cardiac amyloidosis: Strategies to promote early diagnosis and cardiac response","volume":"103","author":"Grogan","year":"2017","journal-title":"Heart"},{"key":"R55-20260904","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijcard.2018.05.018","article-title":"Therapies for cardiac light chain amyloidosis: An update","volume":"271","author":"Aimo","year":"2018","journal-title":"Int J Cardiol"},{"key":"R56-20260904","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/jcm11040911","article-title":"Physiology, diagnosis and treatment of cardiac light chain amyloidosis","volume":"11","author":"Stelmach-Go\u0142dy\u015b","year":"2022","journal-title":"J Clin Med"},{"key":"R57-20260904","doi-asserted-by":"crossref","first-page":"e2018022","DOI":"10.4084\/mjhid.2018.022","article-title":"Light chain amyloidosis","volume":"10","author":"Milani","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R58-20260904","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/ars.2016.6848","article-title":"Cardiac light chain amyloidosis: The role of metal ions in oxidative stress and mitochondrial damage","volume":"27","author":"Diomede","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"R59-20260904","first-page":"1325","article-title":"Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: Redefining early disease?","volume":"13","author":"Cuddy","year":"2020","journal-title":"Cardiovasc Imaging"},{"key":"R60-20260904","doi-asserted-by":"crossref","first-page":"13158","DOI":"10.3390\/ijms222313158","article-title":"A brief journey through protein misfolding in transthyretin amyloidosis (ATTR amyloidosis)","volume":"22","author":"Gonzalez-Duarte","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R61-20260904","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10741-023-10380-9","article-title":"Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy","volume":"29","author":"Wu","year":"2024","journal-title":"Heart Fail Rev"},{"key":"R62-20260904","doi-asserted-by":"crossref","first-page":"131346","DOI":"10.1016\/j.ijcard.2023.131346","article-title":"Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis","volume":"392","author":"Fumagalli","year":"2023","journal-title":"Int J Cardiol"},{"key":"R63-20260904","doi-asserted-by":"crossref","first-page":"e004000","DOI":"10.1161\/CIRCHEARTFAILURE.117.004000","article-title":"Use of serum transthyretin as a prognostic indicator and predictor of outcome in cardiac amyloid disease associated with wild-type transthyretin","volume":"11","author":"Hanson","year":"2018","journal-title":"Circ Heart Fail"},{"key":"R64-20260904","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Eur Heart J"},{"key":"R65-20260904","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/TCRM.S219979","article-title":"Diagnosis and treatment of hereditary transthyretin amyloidosis (hATTR) polyneuropathy: Current perspectives on improving patient care","volume":"16","author":"Luigetti","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"R66-20260904","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10286-018-0514-2","article-title":"Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis)","volume":"29","author":"Gonzalez-Duarte","year":"2019","journal-title":"Clin Auton Res"},{"key":"R67-20260904","first-page":"S107","article-title":"Hereditary ATTR amyloidosis: Burden of illness and diagnostic challenges","volume":"23","author":"Gertz","year":"2017","journal-title":"Am J Manag Care"},{"key":"R68-20260904","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/TCRM.S185677","article-title":"Diagnosis and screening of patients with hereditary transthyretin amyloidosis (hATTR): Current strategies and guidelines","volume":"16","author":"Benson","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"R69-20260904","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10286-019-00629-5","article-title":"Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis","volume":"29","author":"Puig-Carrion","year":"2019","journal-title":"Clin Auton Res"},{"key":"R70-20260904","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12471-019-1299-1","article-title":"Cardiac amyloidosis: The need for early diagnosis","volume":"27","author":"Oerlemans","year":"2019","journal-title":"Neth Heart J"},{"key":"R71-20260904","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12872-018-0952-8","article-title":"Diagnosis of cardiac amyloidosis: A systematic review on the role of imaging and biomarkers","volume":"18","author":"Kyriakou","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"R72-20260904","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1016\/j.echo.2022.06.006","article-title":"Practical points for echocardiography in cardiac amyloidosis","volume":"35","author":"Cuddy","year":"2022","journal-title":"J Am Soc Echocardiogr"},{"key":"R73-20260904","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.echo.2019.03.005","article-title":"Role of right ventricular strain measured by two-dimensional echocardiography in the diagnosis of cardiac amyloidosis","volume":"32","author":"Mo\u00f1ivas Palomero","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"R74-20260904","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s10741-023-10332-3","article-title":"Advance of echocardiography in cardiac amyloidosis","volume":"28","author":"Liang","year":"2023","journal-title":"Heart Fail Rev"},{"key":"R75-20260904","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11886-019-1094-z","article-title":"Echocardiographic findings in cardiac amyloidosis: Inside two-dimensional, Doppler, and strain imaging","volume":"21","author":"Di Nunzio","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"R76-20260904","doi-asserted-by":"crossref","first-page":"695","DOI":"10.6004\/jadpro.2022.13.7.5","article-title":"The role of echocardiogram and cardiac rhythm analysis for early detection of cardiac amyloidosis","volume":"13","author":"Hubert","year":"2022","journal-title":"J Adv Pract Oncol"},{"key":"R77-20260904","doi-asserted-by":"crossref","first-page":"884767","DOI":"10.3389\/fcvm.2022.884767","article-title":"Advanced imaging for risk stratification for ventricular arrhythmias and sudden cardiac death","volume":"9","author":"Xie","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R78-20260904","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s44337-024-00155-y","article-title":"Cardiac imaging to predict malignant arrhythmias in non-ischemic cardiomyopathy","volume":"1","author":"Paterson","year":"2024","journal-title":"Discov Med"},{"key":"R79-20260904","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.mric.2019.04.005","article-title":"The role of cardiac MR imaging in the assessment of patients with cardiac amyloidosis","volume":"27","author":"Carvalho","year":"2019","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"R80-20260904","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tcm.2018.06.011","article-title":"Cardiovascular magnetic resonance imaging for amyloidosis: The state-of-the-art","volume":"29","author":"Tang","year":"2019","journal-title":"Trends Cardiovasc Med"},{"key":"R81-20260904","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11886-019-1180-2","article-title":"Cardiac amyloidosis: Updates in imaging","volume":"21","author":"Chacko","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"R82-20260904","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1007\/s00259-025-07157-7","article-title":"Enhanced diagnostic and prognostic assessment of cardiac amyloidosis using combined (11) C-PiB PET\/CT and (99m) Tc-DPD scintigraphy","volume":"52","author":"Hong","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R83-20260904","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1093\/eurheartj\/ehaa808","article-title":"Risk Assessment in Cardiac Arrhythmias","volume":"41","author":"Sepehri Shamloo","year":"2020","journal-title":"Eur Heart J"},{"key":"R85-20260904","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jacep.2018.06.001","article-title":"Current and future use of insertable cardiac monitors","volume":"4","author":"Giancaterino","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"R86-20260904","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejim.2018.10.013","article-title":"Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study","volume":"60","author":"Bosello","year":"2019","journal-title":"Eur J Intern Med"},{"key":"R87-20260904","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2018.10.079","article-title":"High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure","volume":"277","author":"Aimo","year":"2019","journal-title":"Int J Cardiol"},{"key":"R88-20260904","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/europace\/euac135","article-title":"Machine learning in sudden cardiac death risk prediction: A systematic review","volume":"24","author":"Barker","year":"2022","journal-title":"Europace"},{"key":"R89-20260904","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamacardio.2019.2861","article-title":"Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM risk-kids)","volume":"4","author":"Norrish","year":"2019","journal-title":"JAMA Cardiol"},{"key":"R90-20260904","doi-asserted-by":"crossref","first-page":"166","DOI":"10.18632\/aging.101386","article-title":"Heart rate variability as predictive factor for sudden cardiac death","volume":"10","author":"Sessa","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"R91-20260904","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00414-020-02481-z","article-title":"Sudden cardiac death-update","volume":"135","author":"Markwerth","year":"2021","journal-title":"Int J Legal Med"},{"key":"R92-20260904","doi-asserted-by":"crossref","first-page":"103","DOI":"10.36660\/abchf.20210035","article-title":"Ventricular arrythmias in cardiac amyloidosis: It is possible to prevent sudden death?","volume":"1","author":"Dumont","year":"2021","journal-title":"ABC Heart Fail Cardiomyopathy"},{"key":"R93-20260904","first-page":"1474","article-title":"Sudden death in lambda light chain AL cardiac amyloidosis: A review of literature and update for clinicians and pathologists","volume":"13","author":"D\u2019Errico","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"R94-20260904","first-page":"e65835","article-title":"Recent advances in the management of non-rheumatic atrial fibrillation: A comprehensive review","volume":"16","author":"Kadam","year":"2024","journal-title":"Cureus"},{"key":"R95-20260904","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/ph16060844","article-title":"Overview of cardiac arrhythmias and treatment strategies","volume":"16","author":"Kingma","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"R96-20260904","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"R97-20260904","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCRESAHA.117.310083","article-title":"Calcium signaling and cardiac arrhythmias","volume":"120","author":"Landstrom","year":"2017","journal-title":"Circ Res"},{"key":"R98-20260904","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/CIRCULATIONAHA.118.035455","article-title":"Modernized classification of cardiac antiarrhythmic drugs","volume":"138","author":"Lei","year":"2018","journal-title":"Circulation"},{"key":"R99-20260904","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.3390\/ijms23084096","article-title":"Emerging antiarrhythmic drugs for atrial fibrillation","volume":"23","author":"Saljic","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R100-20260904","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3390\/biomedicines10112888","article-title":"Arrhythmic burden in cardiac amyloidosis: What we know and what we do not","volume":"10","author":"Argir\u00f2","year":"2022","journal-title":"Biomedicines"},{"key":"R101-20260904","doi-asserted-by":"crossref","first-page":"1043714","DOI":"10.3389\/fphar.2022.1043714","article-title":"Beta-blockers in cardiac arrhythmias-clinical pharmacologist\u2019s point of view","volume":"13","author":"Wo\u0142owiec","year":"2022","journal-title":"Front Pharmacol"},{"key":"R102-20260904","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/pharmaceutics15041129","article-title":"Transthyretin stabilizers and seeding inhibitors as therapies for amyloid transthyretin cardiomyopathy","volume":"15","author":"Morfino","year":"2023","journal-title":"Pharmaceutics"},{"key":"R103-20260904","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/eurheartj\/ehz298","article-title":"Treatment of cardiac transthyretin amyloidosis: An update","volume":"40","author":"Emdin","year":"2019","journal-title":"Eur Heart J"},{"key":"R104-20260904","first-page":"121","article-title":"Advancing treatments for transthyretin amyloid cardiomyopathy: Innovations in RNA silencing, gene editing, TTR stabilization, and degradation","volume":"83","author":"Keller","year":"2025","journal-title":"Kardiol Pol"},{"key":"R105-20260904","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejim.2023.10.010","article-title":"Anticoagulation in atrial fibrillation. A large real-world update","volume":"121","author":"Bo","year":"2024","journal-title":"Eur J Intern Med"},{"key":"R106-20260904","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/europace\/euz292","article-title":"The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events","volume":"22","author":"Atar","year":"2020","journal-title":"Europace"},{"key":"R107-20260904","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2206485","article-title":"Efficacy and safety of an extravascular implantable cardioverter-defibrillator","volume":"387","author":"Friedman","year":"2022","journal-title":"N Engl J Med"},{"key":"R108-20260904","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jjcc.2021.10.021","article-title":"Cardiac resynchronization therapy: Current status and near-future prospects","volume":"79","author":"Nakai","year":"2022","journal-title":"J Cardiol"},{"key":"R109-20260904","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.tcm.2020.03.002","article-title":"Wearable cardioverter-defibrillators: A review of evidence and indications","volume":"31","author":"Cheung","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"R110-20260904","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/joa3.12142","article-title":"Implantable loop recorder in clinical practice","volume":"35","author":"Bisignani","year":"2019","journal-title":"J Arrhythm"},{"key":"R111-20260904","doi-asserted-by":"crossref","first-page":"e069530","DOI":"10.1136\/bmjopen-2022-069530","article-title":"Multicentre open label randomised controlled trial of immediate enhanced ambulatory ECG monitoring versus standard monitoring in acute unexplained syncope patients: The ASPIRED study","volume":"13","author":"Reed","year":"2023","journal-title":"BMJ Open"},{"key":"R112-20260904","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.hroo.2020.08.002","article-title":"Secondary prevention of sudden cardiac death","volume":"1","author":"Chatterjee","year":"2020","journal-title":"Heart Rhythm O2"},{"key":"R113-20260904","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.resuscitation.2022.02.019","article-title":"Recurrent ventricular arrhythmias and mortality in cardiac arrest survivors with a reversible cause with and without an implantable cardioverter defibrillator: A systematic review","volume":"173","author":"van der Lingen","year":"2022","journal-title":"Resuscitation"},{"key":"R115-20260904","doi-asserted-by":"crossref","first-page":"37064","DOI":"10.31083\/RCM37064","article-title":"Prevalence of atrial fibrillation and intervention therapy in cardiac amyloidosis","volume":"26","author":"Wu","year":"2025","journal-title":"Rev Cardiovasc Med"},{"key":"R116-20260904","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"R117-20260904","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/europace\/euab162","article-title":"Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy","volume":"24","author":"Bosman","year":"2022","journal-title":"Europace"},{"key":"R118-20260904","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.hrcr.2025.02.020","article-title":"A role for defibrillation threshold testing? A case of ventricular fibrillation refractory to implantable cardioverter-defibrillator shocks in setting of cardiac amyloidosis","volume":"11","author":"Lee","year":"2025","journal-title":"HeartRhythm Case Rep"},{"key":"R119-20260904","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1111\/jce.14180","article-title":"Cardiac devices in patients with transthyretin amyloidosis: Impact on functional class, left ventricular function, mitral regurgitation, and mortality","volume":"30","author":"Donnellan","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R120-20260904","doi-asserted-by":"crossref","first-page":"7","DOI":"10.33963\/KP.a2023.0020","article-title":"Cardiac resynchronization in heart failure: Recent advances and their practical implications","volume":"81","author":"Linde","year":"2023","journal-title":"Kardiol Pol"},{"key":"R121-20260904","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"key":"R122-20260904","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/europace\/euac255","article-title":"Atrial fibrillation and heart failure temporality: does it matter?","volume":"25","author":"Van Deutekom","year":"2023","journal-title":"Europace"},{"key":"R123-20260904","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/europace\/euz314","article-title":"Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis","volume":"22","author":"Donnellan","year":"2020","journal-title":"Europace"},{"key":"R124-20260904","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacep.2023.11.009","article-title":"Remote Monitoring of Cardiac Implantable Electronic Devices: Helping Our Patients Get Online and Stay Connected","volume":"10","author":"Ganesan","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"R125-20260904","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamacardio.2021.0852","article-title":"Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: A meta-analysis of randomized clinical trials","volume":"6","author":"Turagam","year":"2021","journal-title":"JAMA Cardiol"},{"key":"R126-20260904","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12872-024-03983-z","article-title":"Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: A systematic review and meta-analysis","volume":"24","author":"Chander","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"R127-20260904","first-page":"e004328","article-title":"Long-term outcome after catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy","volume":"9","author":"Muser","year":"2016","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"key":"R128-20260904","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.hrthm.2020.07.031","article-title":"The rationale for repurposing funny current inhibition for management of ventricular arrhythmia","volume":"18","author":"Chakraborty","year":"2021","journal-title":"Heart Rhythm"}],"container-title":["Heart Views"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/heartviews.heartviews_167_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:00:28Z","timestamp":1788501628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/heartviews.heartviews_167_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/heartviews.heartviews_167_25","relation":{},"ISSN":["1995-705X","0976-5123"],"issn-type":[{"value":"1995-705X","type":"print"},{"value":"0976-5123","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2026-12-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}